Table 1 Baseline characteristics in the high and low TG/HDL-C index groups.

From: Triglyceride/high density lipoprotein cholesterol index and future cardiovascular events in diabetic patients without known cardiovascular disease

 

TG/HDL-C index ≥ 2.5

TG/HDL-C index < 2.5

P value

n = 2013

n = 2652

Age, y

61.9 ± 11.1

63.8 ± 10.1

 < 0.001

Male, n (%)

1052 (52.3)

1182 (44.6)

 < 0.001

BMI, kg/m2

26.6 ± 4.2

25.0 ± 4.3

 < 0.001

Systolic BP, mmHg

135.6 ± 16.9

134.1 ± 16.3

0.002

Diastolic BP, mmHg

75.8 ± 11.6

74.1 ± 11.1

 < 0.001

Current smoking, n (%)

468 (23.3)

399 (15.1)

 < 0.001

Hypertension, n (%)

1490 (74.0)

1811 (68.3)

 < 0.001

Duration of T2DM, y

12.5 ± 8.5

13.4 ± 9.0

0.001

eGFR, mL/min/1.73 m2

72.4 ± 21.2

75.4 ± 19.6

 < 0.001

HbA1c, %

5.6 ± 0.6

5.6 ± 0.6

 < 0.001

LDL-C, mg/dL

113.3 ± 26.1

106.5 ± 24.8

0.68

HDL-C, mg/dL

47.1 ± 9.3

62.2 ± 13.3

 < 0.001

TG, mg/dL

203.5 ± 97.0

91.3 ± 27.6

 < 0.001

Non HDL-C, mg/dL

145.4 ± 31.7

124.5 ± 26.1

 < 0.001

ApoB, mg/dL

101.1 ± 21.3

86.3 ± 17.2

 < 0.001

BNP, pg/dL*

13.1 (6.7, 27.3)

16.2 (8.3, 30.6)

0.014

ACEI or ARB

1111 (55.2)

1311 (49.4)

 < 0.001

CCB

797 (39.6)

912 (34.4)

 < 0.001

β-blocker

115 (5.7)

107 (4.0)

0.008

Diuretic

263 (13.1)

289 (10.9)

0.023

MRA

31 (1.5)

21 (0.8)

 < 0.001

  1. Values are numbers (%) or mean ± SD except for BNP. *Median value and interquartile range are shown in parentheses. ACEI, angiotensin-converting enzyme inhibitor; ApoB, apolipoprotein B; ARB, angiotensin II receptor blocker; BMI, body mass index; BNP, B-type natriuretic peptide; BP, blood pressure; CCB, calcium channel blocker; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MRA, mineralocorticoid receptor antagonist; T2DM, type 2 diabetes mellitus; TG, triglyceride.
Back to article page